Amid the financial shock waves being sent by the release of DeepSeek's open source artificial intelligence R1 model, ...

Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $1.94 which represents a slight increase of $0.06 or 3.19% from the prior close of $1.88. The stock opened at $1.87 and ...

H.C. Wainwright reaffirmed a Buy rating and a $40.00 price target for Exelixis (NASDAQ:EXEL) shares, following recent clinical trial results. Currently trading at $32.38, the stock has shown strong ...